Browse the corpus

Walk the Even Hospital Database by book and chapter — the raw source passages that ground Ask, DDx, and the rest.

1 passage

referencesuptodate· REFERENCES· item f39_0_39942

REFERENCES Berntorp E, “Plasma Product Treatment in Various Types of von Willebrand Disease,” Haemostasis , 1994, 24(5):289-97. [PubMed 7843640 ] Berntorp E and Windyga J, “Treatment and Prevention of Acute Bleeding in von Willebrand Disease -- Efficacy and Safety of Wilate®, A New Generation von Willebrand Factor/Factor VIII Concentrate,” Haemophilia , 2009, 15(1):122-30. [PubMed 19149848 ] Federici AB, “Clinical Diagnosis of von Willebrand's Disease,” Haemophilia , 2004, 10(Suppl 4):169-76. Kreuz W, Mentzer D, Becker S, et al, “Haemate P in Children With von Willebrand's Disease,” Haemostasis , 1994, 24(5):304-10. [PubMed 7843642 ] Peterson CW, “Treating Hemophilia,” Am Pharm , 1994, NS34(8):57-67. Scharrer I, Vigh T, and Aygoren-Purun E, “Experience With Haemate P in von Willebrand's Disease in Adults,” Haemostasis , 1994, 24(5):298-303. [PubMed 7843641 ] White GC, Rosendaal F, Aledort LM, et al, “Definitions in Hemophilia. Recommendation of the Scientific Subcommittee on Factor VIII and Factor IX of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis,” Thromb Haemost , 2001, 85(3):560. [PubMed 11307831 ] Topic 8782 Version 33.0 © 2013 UpToDate, Inc. All rights reserved. | Subscription and License Agreement | Release: 21.4 - C21.36 Licensed to: Southeast Alabama Med Ctr | Support Tag: [1104-60.18.131.125-4DC6258CCE-S244013.14]